Interv Akut Kardiol. 2010;9(2):70-74

Catheter ablation of atrial fibrillation: from patient selection to follow-up considerations

Dan Wichterle
Klinika kardiologie IKEM a Klinika kardiologie a angiologie VFN, Praha

Catheter ablation for atrial fibrillation (AF) has gained wide acceptance as an important therapeutic modality for the treatment of

patients with symptomatic recurrent AF. According to several randomized trials, catheter ablation for AF is superior to continuing pharmacologic

treatment when at least one antiarrhythmic drug failed to control the AF. In these studies, the ablation strategy resulted to

freedom from AF recurrence, improvement in AF burden and improvement in quality of life. However, because catheter ablation for

AF is a demanding technical procedure that may result in serious complications, patients should only undergo AF ablation after carefully

weighing the risks and benefits of the procedure. Meticulous clinical approach is required to identify the patients most likely to

respond to catheter ablation. Not only diligently performed ablation procedure but also pre- and post-procedural management of patients

in collaboration with referring physicians is crucial for final clinical success. The randomized controlled studies are ongoing aimed

at establishing AF ablation as first-line treatment and demonstrating that the effect of catheter ablation for AF translates into improved

clinical outcomes and reduction in overall mortality.

Keywords: atrial fibrillation, catheter ablation, patient selection

Published: April 1, 2010  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Wichterle D. Catheter ablation of atrial fibrillation: from patient selection to follow-up considerations. Interv Akut Kardiol. 2010;9(2):70-74.
Download citation

References

  1. Fuster V, Ryden LE, Cannom DS, et al. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation. Circulation 2006; 114: 257-354. Go to original source... Go to PubMed...
  2. Calkins H, Brugada J, Packer DL, et al. HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for personnel, policy, procedures, and follow-up. Heart Rhythm 2007; 4: 816-861. Go to original source... Go to PubMed...
  3. Pappone C, Augello G, Sala S, et al. A randomized trial of circumferential pulmonary vein ablation versus antiarrhythmic drug therapy in paroxysmal atrial fibrillation: the APAF Study. J Am Coll Cardiol 2006; 48: 2340-2347. Go to original source... Go to PubMed...
  4. Jais P, Cauchemez B, Macle L, et al. Catheter Ablation Versus Antiarrhythmic Drugs for Atrial Fibrillation: The A4 Study. Circulation. 2008; 118: 2498-2505. Go to original source... Go to PubMed...
  5. Stabile G, Bertaglia E, Senatore G, et al. Catheter ablation treatment in patients with drug-refractory atrial fibrillation: a prospective, multi-centre, randomized, controlled study (Catheter Ablation For The Cure Of Atrial Fibrillation Study). Eur Heart J 2006; 27: 216-221. Go to original source... Go to PubMed...
  6. Forleo GB, Mantica M, De Luca L, et al. Catheter ablation of atrial fibrillation in patients with diabetes mellitus type 2: results from a randomized study comparing pulmonary vein isolation versus antiarrhythmic drug therapy. J Cardiovasc Electrophysiol 2009; 20: 22-8. Go to original source... Go to PubMed...
  7. Oral H, Pappone C, Chugh A, et al. Circumferential pulmonary vein ablation for chronic atrial fibrillation. N Engl J Med 2006; 354: 934-941. Go to original source... Go to PubMed...
  8. Wazni O, Marrouche NF, Martin DO, et al. Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of symptomatic atrial fibrillation: a randomized trial. JAMA 2005; 293: 2634-2640. Go to original source... Go to PubMed...
  9. Nair GM, Nery PB, Diwakaramenon S, et al. A systematic review of randomized trials comparing radiofrequency ablation with antiarrhythmic medications in patients with atrial fibrillation. J Cardiovasc Electrophysiol 2009; 20: 138-44. Go to original source... Go to PubMed...
  10. Hsu LF, Jais P, Sanders P, et al. Catheter ablation for atrial fibrillation in congestive heart failure. N Engl J Med 2004; 351: 2373-2383. Go to original source... Go to PubMed...
  11. Khan MN, Jais P, Cummings J, et al. PABA-CHF Investigators. Pulmonary-vein isolation for atrial fibrillation in patients with heart failure. N Engl J Med 2008; 359: 1778-1785. Go to original source... Go to PubMed...
  12. Matsuo S, Lellouche N, Wright M, et al. Clinical predictors of termination and clinical outcome of catheter ablation for persistent atrial fibrillation. J Am Coll Cardiol 2009; 54: 788-795. Go to original source... Go to PubMed...
  13. Oakes RS, Badger TJ, Kholmovski EG, et al. Detection and quantification of left atrial structural remodeling with delayed-enhancement magnetic resonance imaging in patients with atrial fibrillation. Circulation 2009; 119: 1758-1767. Go to original source... Go to PubMed...
  14. Kautzner J, Peichl P, Mlčochová H. Robotická navigace při katetrizačních ablacích. Interv Akut Kardiol 2008; 7: 188-191.
  15. Peichl P, Kautzner J. Využití intrakardiální echokardiografie v elektrofyziologii a intervenční kardiologii. Interv Akut Kardiol 2008; 7: 67-72.
  16. Singh JP, Morady F. Patient selection and classification for atrial fibrillation ablation: Thinking beyond duration. Heart Rhythm 2009; 6: 1522-1525. Go to original source... Go to PubMed...
  17. Cappato R, Calkins H, Chen SA, et al. Worldwide survey on the methods, efficacy and safety of catheter ablation of human atrial fibrillation. Circulation 2005; 111: 1100-1105. Go to original source... Go to PubMed...
  18. Peichl P, Mlčochová H, Čihák R, et al. Selektivní katetrizační ablace fibrilace síní: potenciální komplikace výkonu a možnosti jejich prevence. Interv Akut Kardiol 2008; 7: 226-229.
  19. Hindricks G, Piorkowski C, Tanner H, et al. Perception of atrial fibrillation before and after radiofrequency catheter ablation: relevance of asymptomatic arrhythmia recurrence. Circulation 2005; 112: 307-313. Go to original source... Go to PubMed...
  20. Fiala M. Role katetrové ablace fibrilace síní v prevenci tromboembolické cévní mozkové příhody. Interv Akut Kardiol 2008; 7: 143-146.
  21. Gage BF, Waterman AD, Shannon W, et al. Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. JAMA 2001; 285: 2864-2870. Go to original source... Go to PubMed...




Interventional Cardiology

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.